Login / Signup

Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation.

Hangyuan QiuYaxun SunZiwei PanJingjun ZhouHongkun WangXiaochen WangDongsheng CaiGuosheng FuTingyu GongChenyang JiangPing Liang
Published in: Clinical and translational medicine (2022)
Keyphrases
  • hypertrophic cardiomyopathy
  • high glucose
  • endothelial cells
  • left ventricular
  • diabetic rats
  • induced pluripotent stem cells
  • pluripotent stem cells
  • heart failure
  • mouse model
  • oxidative stress